+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genomics Market - Forecast (2020 - 2025)

  • ID: 3339395
  • Report
  • March 2020
  • Region: Global
  • 102 pages
  • IndustryARC
1 of 3
Global Genomic Market Overview:

A genome is the genetic material of an organism. It includes both the genes and the noncoding DNA, as well as mitochondrial DNA and chloroplast DNA. The study of genomes is called genomics. The genomics market is gaining traction owing to its applications in various fields of study such as intragenomic phenomenon including epistasis, pleiotropy, heterosis, and other interactions between loci and alleles within the genome. In this era of medical and life science innovations shaping itself as an inevitable uptake for sustainability of mankind, the genomic research is poised for exponential growth owing to imperative genetic innovations feeding off it. Abundant potential has driven this arcade to reach a staggering market size of $16 billion - $16.5 billion as of 2018, and the demand is estimated to increment at formidable CAGR of 9.2% to 10.2% during the forecast period of 2019 to 2025.

Global Genomic Market Outlook:

Genomics is extensively employed in healthcare, agriculture, biotechnology, DNA sequencing, and diagnostics. In the healthcare segment, genomics is used for the development of vaccines and drugs. This segment leads the application vertical and is growing with a CAGR of 10.1%-10.7 % through to 2025. Genomics plays a significant part in diagnosis of several genetic disorders. It has an ample scope in personalized medication as it can advocate a medical management constructed on the genetic face of a person with the help of clinical data and AI.  It is also applied in synthetic biology and bioengineering. Genomics research in agriculture is hired for plant breeding and genetics to cultivate crop production. The understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant will aid the plant breeders to identify the traits and then manipulate those traits to obtain a high yield. All these factors affecting the enormous medical and agricultural sector are all set to stroke the genomics market with abundant demand.

Global Genomic Market Growth Drivers:

As per the National Center for Biotechnology Information, U.S, the progression in oncology (study and treatment of tumor) expenses is forecast to rise 7%–10% annually throughout 2020, with universal oncology cost exceeding $150 billion[1]. As per the WHO, cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018[2]. And the total annual economic cost of cancer at the initial period of this decade was estimated at approximately $1.16 trillion. Thus the application of genomics in exploring cell-free circulating DNA by several R&D sectors as a potential biomarker for cancers is driving the market towards exponential growth. The genomics market with its current potential displays all the necessary traits it can adapt in the coming years to divert a huge chunk of traffic and revenue from the omnipresent cancer diagnostics.

As per the Food and Agriculture Organization of United Nations, between 1960 and 1990 the arable land increased by 1.5 billion ha, and in the recent past decades the elevation recorded is just 155 million ha[3]. With decreasing arable floor and the increasing global population augmenting the demand for food by 70% (by 2050), obtaining a high yield is a major trend in the agricultural sector. Genomics market is all set to capitalize on this unprecedented demand scenario. Genomics supplements the understanding of gene function and the accessibility of genomic maps along with an enhanced understanding of genetic variant, thus aiding the plant breeders to identify the traits and then manipulate those traits to obtain a high yield.

After an acute analysis of the regional insights of the global genomics market, North America is revealed to hold 39% to 40% of the entire global market size as of 2018. Such dominance can be attributed to several aspects such as cumulative investment on research by federal administrations, growing patient awareness, and accessibility of urbane healthcare facilities.

Genomics Market

Global Genomics Market Players Perspective:

Some of other key players profiled in this business intelligence report are Beckton Dickson, Synthetic Genomics Inc. (SGI) ,Cepheid, Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, GE Healthcare, Illumina, Inc., Danaher Corporation,F. Hoffmann-La Roche, QIAGEN, Thermo Fisher Scientific and PacBio (Pacific Biosciences of California). Majority of the companies mentioned are situated in North America augmenting the regional affluence in the global market.

Global Genomics Market Trends:

High overload owing to a wide range of reagents and consumables has propelled companies into approving different policies to endure in the market and stay ahead of the curve.

For instance, in January 2017, BD launched Precise WTA Reagents for precise and guileless quantification of hereditary data form single cell analysis. Moreover, in July 2016, SGI-DNA entered into a distribution agreement with VWR International, an American company involved in the distribution of research laboratory products, with over 1,200,000 items to more than 250,000 customers in North America and Europe.

Genomics Market Research Scope

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Genomics Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of equipment in the Genomics Market, and their specific applications in different phases of industrial operations.

Genomics Market Report: Industry Coverage

Types of Solutions Genomics Market:

By Product Types- Microarray chip, Sequencers.

By Application- Genotyping, SNP analysis.

By End-User- Anthropology, Diagnostics.

The Genomics Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia


This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 3
1. Genomics Market - Overview
1.1. Definitions and Scope

2. Genomics Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography

3. Genomics Market
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 8 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 8 companies
3.1.4. Patent Analysis - Top 8 companies
3.1.5. Pricing Analysis

4. Genomics Market Forces
4.1. Drivers
4.2. Constraints
4.3. Challenges
4.4. Porters five force model
4.4.1. Bargaining power of suppliers
4.4.2. Bargaining powers of customers
4.4.3. Threat of new entrants
4.4.4. Rivalry among existing players
4.4.5. Threat of substitutes

5. Genomics Market -Strategic analysis
5.1. Value chain analysis
5.2. Opportunities analysis
5.3. Product life cycle
5.4. Suppliers and distributors Market Share

6. Genomics Market – By Product Type (Market Size -$Million / $Billion)
6.1. Market Size and Market Share Analysis
6.2. Application Revenue and Trend Research
6.3. Product Segment Analysis
6.3.1. Introduction
6.3.2. Products
6.3.2.1. Microarray Chips
6.3.2.2. DNA Sequencers
6.3.2.3. Thermal Cyclers
6.3.2.4. Electrophoresis Equipment
6.3.2.5. Mass Spectrometers
6.3.2.4. Others
6.3.3. Reagents Used

7. Genomics Market – Service Industry Analysis (Market Size -$Million / $Billion)
7.1. Introduction
7.2. Bio-Informatics Database
7.3. Bio-Informatics Tools
7.4. Laboratory Services
7.4.1. DNA Sample Sequencing
7.4.2. De Novo Sequencing
7.4.3. Targeted Re-Sequencing
7.4.4. Individual Genome Sequencing
7.4.5. SNP Analysis
7.4.4. Molecular Biology
7.4.5. Gene Expression Analysis
7.4.6. Biomarker Solutions
7.4.7. Others

8. Genomics Market – By Technique (Market Size -$Million / $Billion)
8.1. PCR
8.2. Microarray analysis
8.3. Chromatography
8.4. X-ray crystallography
8.5. Electrophoresis
8.4. Others

9. Genomics Market – By Application (Market Size -$Million / $Billion)
9.1. Genotyping
9.2. Epigenetics
9.3. Gene expression and transcriptome analysis
9.4. Cytogenomics
9.5. Personalized medicine
9.4. Proteomics
9.5. Vaccine synthesis
9.6. Synthetic Biology and Bioengineering
9.9. Drug discovery
9.8. Gene mapping
9.9. Social science
9.10. Others

10. Genomics – By End Use Industry(Market Size -$Million / $Billion)
10.1. Segment type Size and Market Share Analysis
10.2. Application Revenue and Trends by type of Application
10.3. Application Segment Analysis by Type
10.3.1. Introduction
10.3.2. Anthropology
10.3.3. Agriculture
10.3.4. Biotechnology
10.3.5. Diagnostics
10.3.4. Medicine
10.3.5. Others

11. Genomics - By Geography (Market Size -$Million / $Billion)
11.1. Genomics Market - North America Segment Research
11.2. North America Market Research (Million / $Billion)
11.2.1. Segment type Size and Market Size Analysis
11.2.2. Revenue and Trends
11.2.3. Application Revenue and Trends by type of Application
11.2.4. Company Revenue and Product Analysis
11.2.5. North America Product type and Application Market Size
11.2.5.1. U.S.
11.2.5.2. Canada
11.2.5.3. Mexico
11.2.5.4. Rest of North America
11.3. Genomics - South America Segment Research
11.4. South America Market Research (Market Size -$Million / $Billion)
11.4.1. Segment type Size and Market Size Analysis
11.4.2. Revenue and Trends
11.4.3. Application Revenue and Trends by type of Application
11.4.4. Company Revenue and Product Analysis
11.4.5. South America Product type and Application Market Size
11.4.5.1. Brazil
11.4.5.2. Venezuela
11.4.5.3. Argentina
11.4.5.4. Ecuador
11.4.5.5. Peru
11.4.5.4. Colombia
11.4.5.5. Costa Rica
11.4.5.6. Rest of South America
11.5. Genomics - Europe Segment Research
11.4. Europe Market Research (Market Size -$Million / $Billion)
11.4.1. Segment type Size and Market Size Analysis
11.4.2. Revenue and Trends
11.4.3. Application Revenue and Trends by type of Application
11.4.4. Company Revenue and Product Analysis
11.4.5. Europe Segment Product type and Application Market Size
11.4.5.1. U.K
11.4.5.2. Germany
11.4.5.3. Italy
11.4.5.4. France
11.4.5.5. Netherlands
11.4.5.4. Belgium
11.4.5.5. Spain
11.4.5.6. Denmark
11.4.5.7. Rest of Europe
11.5. Genomics – APAC Segment Research
11.6. APAC Market Research (Market Size -$Million / $Billion)
11.6.1. Segment type Size and Market Size Analysis
11.6.2. Revenue and Trends
11.6.3. Application Revenue and Trends by type of Application
11.6.4. Company Revenue and Product Analysis
11.6.5. APAC Segment – Product type and Application Market Size
11.6.5.1. China
11.6.5.2. Australia
11.6.5.3. Japan
11.6.5.4. South Korea
11.6.5.5. India
11.6.5.4. Taiwan
11.6.5.5. Malaysia

12. Genomics Market - Entropy
12.1. New product launches
12.2. M&A's, collaborations, JVs and partnerships

13. Genomics Market Company Analysis
13.1. Market Share, Company Revenue, Products, M&A, Developments
13.2. Luminex Corporation
13.3. Myriad Genetics Inc
13.4. Thermo Fisher Scientific Inc.
13.5. Pacific Biosciences of California, Inc
13.4. Ge Healthcare
13.5. Perkinelmer Inc.
13.6. Bayer Healthcare Llc
13.7. F. Hoffmann-La Roche Ltd
13.8. Illumina, Inc.
13.9. Agilent Technologies Inc.
13.10. Bio-Rad Laboratories
13.11. Qiagen N.V.

14. Genomics Market -Appendix
14.1. Abbreviations
14.2. Sources
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

Adroll
adroll